Table I.
Patient characteristic | Result |
---|---|
Median Age (years) | 63 years (range, 43-77) |
Male/Female (n) | 6/5 |
AML rising from AHD (n) | 4 |
t-AML (n) | 1 |
Refractory AML (n) | 4 |
Relapsed AML (n) | 7 |
ELN* genetic group | |
Intermediate II | 7 |
Adverse | 4 |
Prior anthracycline exposure (n) | 10 |
Median number prior regimens (n) | 2 (range, 1-4) |
AHD, antecedent hematologic disorder, t-AML, therapy-related AML,
See ref.32